Non-alcoholic fatty liver disease and 30-day all-cause mortality in adult patients with community-acquired pneumonia
Authors:
- 16 October 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 112 (2) , 95-99
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a common and serious form of chronic liver disease. Risk factors of NAFLD include obesity and type 2 diabetes which are associated with infections. We aimed to determine the association of NAFLD with 30-day all-cause mortality in adult patients with community-acquired pneumonia (CAP). A retrospective cohort study on hospitalized patients with CAP that was conducted during a period of 4 years. We included patients aged ≥ 18 years with CAP who underwent abdominal ultrasonography. We compared between patients with and without NAFLD in term of age, gender, body mass index (BMI), comorbidities, CURB-65, pneumonia severity index (PSI), liver enzymes, C-reactive protein (CRP), and 30-day all-cause mortality. We used fibrosis score to distinguish between patients with NAFLD who have advanced fibrosis (F3-F4) and do not have (F0-F2). A total of 561 patients were included in this study. The overall prevalence of NAFLD was 200/561 (35.6%). Significant differences were found between the groups with and without NAFLD in term of BMI, CURB-65, ALT, GGT, and CRP. The 30-day all-cause mortality rate was 9.8% (55/561). Among the NAFLD group 34/200(17%) subjects died vs. 21/361 (5.82%) among patients without NAFLD, P < 0.001. Multivariate logistic regression analysis after adjusting for other multiple covariates showed that NAFLD with fibrosis score 0-2 (odds ratio (OR) 1.38, 95% confidence interval (CI)1.12- 1.51, P = 0.04), NAFLD with fibrosis score > 2 (1.52; 1.25-1.70, P = 0.03) were associated with 30-day all-cause mortality among patients with CAP. NAFLD was associated with 30-day all-cause mortality in patients with CAP. This association was more significant in patients with advanced hepatic fibrosis.Keywords
This publication has 26 references indexed in Scilit:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Fatty Liver Is Associated with Recurrent Bacterial Infections Independent of Metabolic SyndromeDigestive Diseases and Sciences, 2011
- Soft drinks consumption and nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology, 2010
- BTS guidelines for the management of community acquired pneumonia in adults: update 2009Thorax, 2009
- The changing epidemiology of resistanceJournal of Antimicrobial Chemotherapy, 2009
- The NAFLD fibrosis scoreHepatology, 2007
- Innate immunity in the liverCurrent Opinion in Gastroenterology, 2003
- Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic SyndromeHepatology, 2003
- Apolipoprotein synthesis in nonalcoholic steatohepatitisHepatology, 2002
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998